Link to this page
Cell Culture Ontology
Id | http://www.ebi.ac.uk/efo/EFO_0005800
http://www.ebi.ac.uk/efo/EFO_0005800
|
---|---|
Preferred Name | substance withdrawal syndrome |
Definitions |
A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of a substance (including alcohol, prescribed medications and recreational drugs). Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.
A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.
|
Synonyms |
withdrawal disorder
substance withdrawal syndrome
substance withdrawal disorder
drug withdrawal syndrome
substance withdrawal
withdrawal syndrome
drug withdrawal
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition | A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of a substance (including alcohol, prescribed medications and recreational drugs). Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. |
---|---|
preferred label |
substance withdrawal syndrome
|
label |
substance withdrawal syndrome
|
prefLabel |
substance withdrawal syndrome
|
database_cross_reference |
DOID:0060001
NCIt:C35046
NCIT:C35046
SCTID:363101005
UMLS:C0038587
MESH:D013375
MeSH:D013375
MONDO:0005567
MEDGEN:20990
ICD9:292.0
See more
See less
|
IAO_0000233 | |
notation |
EFO:0005800
|
in_subset | |
has_related_synonym |
withdrawal disorder
|
id |
EFO:0005800
|
skos_exactMatch |
See more
See less
|
subClassOf | |
type | |
has_exact_synonym |
substance withdrawal syndrome
substance withdrawal disorder
drug withdrawal syndrome
substance withdrawal
withdrawal syndrome
drug withdrawal
See more
See less
|
excluded_subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |